ZS Ph2/3 Dose-response Study in Japan

Trial Identifier: D9482C00002
Sponsor:AstraZeneca
NCTID:NCT03127644
Start Date:June 2017
Primary Completion Date: February 2018
Study Completion Date: February 2018
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

LanguageDescription
Japanese Translation
English Translation

Trial Locations

CountryLocation
Japan Chiba-shi, Japan, 260-8712
Japan Chiba-shi, Japan, 263-0043
Japan Hanyu-shi, Japan, 348-8505
Japan Higashiibaraki-gun, Japan, 311-3193
Japan Hitachinaka-shi, Japan, 312-0057
Japan Ina-shi, Japan, 396-8555
Japan Kagoshima-shi, Japan, 892-8580
Japan Kahoku-gun, Japan, 920-0293
Japan Kamakura-shi, Japan, 247-8533
Japan Kanazawa-shi, Japan, 920-8650
Japan Kasugai-shi, Japan, 486-8510
Japan Kawachinagano-shi, Japan, 586-8521
Japan Kawasaki-shi, Japan, 216-8511
Japan Kitakyushu-shi, Japan, 802-0001
Japan Koga-shi, Japan, 306-0041
Japan Kusatsu-shi, Japan, 525-8585
Japan Matsudo-shi, Japan, 271-0077
Japan Matsuyama-shi, Japan, 791-8026
Japan Nagoya-shi, Japan, 457-8511
Japan Naka-shi, Japan, 311-0113
Japan Omura-shi, Japan, 856-8562
Japan Shimajiri-gun, Japan, 901-0493
Japan Shizuoka-shi, Japan, 421-0117
Japan Yao-shi, Japan, 581-0011
Japan Yotsukaido-shi, Japan, 284-0027